Skip to main content

Idarucizumab given the nod as the first specific antidote for an oral anticoagulant

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Idarucizumab given the nod as the first specific antidote for an oral anticoagulant

User login

Username

Password

Reset your password

Type	Lead	score